Sign In
Buy ARWR
$82.00
+0.180 (+0.220%)
At Close: Jun 22, 2026
Geode Capital Management LLC Buys 83,282 Shares of Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR)
07:16am, Sunday, 21'st Jun 2020
Geode Capital Management LLC boosted its stake in shares of Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR) by 5.8% in the first quarter, HoldingsChannel reports. The institutional investor owned 1,515,64
Alliancebernstein L.P. Sells 6,810 Shares of Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR)
06:00am, Saturday, 20'th Jun 2020
Alliancebernstein L.P. reduced its stake in Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR) by 2.1% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange
An Evolving Portfolio Strategy
11:40pm, Thursday, 18'th Jun 2020
I have a hybrid Growth/DGI/Medium Yield Portfolio. During the COVID-19 crash, I removed several high-yield names, adding new DGI and medium-yield names, and sho
An Evolving Portfolio Strategy
07:40pm, Thursday, 18'th Jun 2020
I have a hybrid Growth/DGI/Medium Yield Portfolio. During the COVID-19 crash, I removed several high-yield names, adding new DGI and medium-yield names, and sho
Victory Capital Management Inc. Has $7.15 Million Stock Position in American Assets Trust, Inc (NYSE:AAT)
07:24am, Thursday, 18'th Jun 2020
Victory Capital Management Inc. lowered its stake in shares of American Assets Trust, Inc (NYSE:AAT) by 77.0% during the first quarter, according to the company in its most recent filing with the Secu
Is Arrowhead Pharmaceuticals Inc. (ARWR) A Good Stock To Buy?
01:46am, Wednesday, 17'th Jun 2020
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings. The 13F filings show the hedge funds' and succes
ARWR: Multiple ‘Shots on Goal’ for RNAi Platform…
01:30pm, Tuesday, 16'th Jun 2020
By David Bautz, PhD NASDAQ:ARWR READ THE FULL ARWR RESEARCH REPORT Business Update Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR) is developing medicines that cause gene silencing using RNA interference
Quietly Adding More Shares Of Arrowhead Pharmaceuticals (NASDAQ:ARWR)
05:23pm, Friday, 12'th Jun 2020
Many stocks have rebounded noticeably on market exuberance lately, but not Arrowhead Pharmaceuticals. Arrowhead's pipeline continues to progress markedly as goo
JPMorgan Chase & Co. Has $11.91 Million Stake in Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR)
05:28am, Wednesday, 10'th Jun 2020
JPMorgan Chase & Co. decreased its holdings in Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR) by 27.7% in the 1st quarter, Holdings Channel.com reports. The firm owned 413,937 shares of the biotechnology
Will Johnson & Johnson Acquire Arrowhead Pharmaceuticals?
04:35pm, Tuesday, 02'nd Jun 2020
Will the pharma giant be interested in acquiring a mid-cap partner with a promising treatment for hepatitis B?
10-K/A: AMERICAN RESOURCES CORP
01:04pm, Monday, 01'st Jun 2020
(EDGAR Online via COMTEX) --
Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations. The following Management's...
Edited Transcript of ARWR earnings conference call or presentation 7-May-20 8:30pm GMT
10:35pm, Saturday, 30'th May 2020
Q2 2020 Arrowhead Pharmaceuticals Inc Earnings Call
Arrowhead Pharmaceuticals to Participate in Upcoming June 2020 Conferences
11:30am, Thursday, 28'th May 2020
Arrowhead Pharmaceuticals will present at Jefferies and Goldman Sachs healthcare conferences in June 2020
Is Arrowhead Pharmaceuticals a Buy?
02:10pm, Sunday, 24'th May 2020
The development-stage genetic medicine company is eager to convert its intriguing potential into tangible progress.
Arrowhead Pharmaceuticals Is Likely to See a Trading Range Market Ahead
03:34pm, Friday, 22'nd May 2020
The "Lightning Round" segment of the popular Mad Money program is a viewer favorite. Callers get a chance to ask Jim Cramer about stocks they are interested in. One caller Thursday night asked about
